India to Uzbekistan: Ifosfamide Export Trade Route

The India to Uzbekistan Ifosfamide corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $614.3K USD. The route is dominated by VIVALIA REMEDIES PRIVATE LIMITED , which alone accounts for roughly 97% of all export value, reflecting the consolidated nature of India's ifosfamide manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $68.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with ifosfamide's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 33.2%, placing it at rank #10 among India's top ifosfamide export destinations globally.

On the import side, key buyers of Indian ifosfamide in Uzbekistan include VEF SAU , LLC OZMEDIMPEKS , ALINFARM MEDICAL CO LIMITED and 3 others. VEF SAU is the single largest importer with 3 shipments valued at $480.0K USD.

India's ifosfamide exports to Uzbekistan are driven primarily by a handful of large-scale manufacturers. VIVALIA REMEDIES PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Uzbekistan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VIVALIA REMEDIES PRIVATE LIMITED , VIVALIA REMEDIES PRIVATE LIMITED, APRAZER HEALTHCARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $68.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as fosfa + mesna (ifosfamide 1gm with mesn and fosfa 1g ifosfamide for inj. with mesna 2 mlbatch no. 3gip09 manufacturing .dt. 08/2023 exp.dt. 07/2025 batch no. 3gms14 manufacturing .d, suggesting that buyers in Uzbekistan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, VEF SAU is the largest importer with 3 shipments worth $480.0K USD — representing 78% of all ifosfamide imports from India on this route. A total of 6 buyers are active on this corridor.